Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga September 26, 2014 at 08:02 AM EDT Repros Therapeutics (NASDAQ: RPRX) shares jumped 15.51% to $10.35 in pre-market trading following the announcement that Androxal ZA-304 ... Read More >> Related Stocks: Micron Technology Nike Inc